Announced Tue, 5 May · 20:20 IST

Emcure Pharmaceuticals Limited has informed the Exchange about Link of Recording

Investor Communications View source PDF

EMCURE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.9%1-day move
₹1689.00
prior close
₹1705.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-3.1-4.1-3.4-2.8-1.9-2.5-0.8-1.9-2.0+1.0+2.1+1.8+8.6
Up moveDown movePending
AI summary

Emcure Pharmaceuticals has informed the NSE and BSE that the audio recording of their Q4 FY26 earnings call held on May 05, 2026, is now available on the company's website. This is a routine regulatory disclosure under SEBI LODR Regulations 2015, notifying investors where they can access the earnings call replay. The actual content of the call (financials, guidance, Q&A) is not included in this filing but would be in the audio file at the provided link.

Likely market impact

This filing is informational only and does not contain any new material information. Investors interested in the Q4 FY26 earnings call details should listen to the recording directly on the Emcure website.